Logotyp: till Uppsala universitets webbplats

uu.sePublikationer från Uppsala universitet
Ändra sökning
Länk till posten
Permanent länk

Direktlänk
Ställberg, Björn, DocentORCID iD iconorcid.org/0000-0001-8497-7326
Alternativa namn
Publikationer (10 of 187) Visa alla publikationer
Athlin, A., Lisspers, K., Hasselgren, M., Ställberg, B., Sandelowsky, H., Giezeman, M., . . . Sundh, J. (2027). Comorbid asthma - occurrence and associations with patient-related outcomes in COPD: a cohort study. Scandinavian Journal of Primary Health Care, 45(1), Article ID 2747915.
Öppna denna publikation i ny flik eller fönster >>Comorbid asthma - occurrence and associations with patient-related outcomes in COPD: a cohort study
Visa övriga...
2027 (Engelska)Ingår i: Scandinavian Journal of Primary Health Care, ISSN 0281-3432, E-ISSN 1502-7724, Vol. 45, nr 1, artikel-id 2747915Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Purpose

Clinical features of COPD and asthma overlap, complicating differential diagnosis. This study investigated the prevalence of comorbid asthma in COPD patients and its association with patient-related outcomes.

Materials and methods

Patients with a doctor's diagnosis of COPD were randomly selected in two cohorts 2005 (n = 1060) and 2014 (n = 1671), from primary and secondary care in Sweden. Data were collected from medical records and patient questionnaires at baseline and at follow-up (2012 and 2022, respectively). Questionnaires included data on exacerbations. Symptoms were assessed using the clinical COPD questionnaire (CCQ). Comorbid asthma was identified through medical records. Ten-year mortality data were obtained from national registers. Logistic and linear regression assessed associations with patient-reported outcomes; Cox regression was applied for mortality analyses.

Results

Comorbid asthma was found in 22% of the 2005 cohort and 9% of the 2014 cohort (p < .001). In both cohorts, it was associated with an increased risk of exacerbations: OR (95% CI) 1.58 (1.07-2.32), p = .02, and 2.20 (1.38-3.52), p < .001, respectively. No associations were found between comorbid asthma and worsening of health status (CCQ). Mortality risk did not differ in the 2005 cohort, HR (95% CI) 0.92 (0.71-1.18), but was lower in the 2014 cohort, HR (95% CI) 0.67 (0.49-0.93), p = .02.

Conclusion

Comorbid asthma in COPD has changed from 22 to 9%, potentially due to improved diagnostics. Comorbid asthma remains clinically relevant due to its association with an increased exacerbation risk.

Ort, förlag, år, upplaga, sidor
Taylor & Francis, 2027
Nyckelord
Primary care, real-life, mortality, exacerbation, clinical COPD questionnaire, Comorbid asthma
Nationell ämneskategori
Lungmedicin och allergi
Identifikatorer
urn:nbn:se:uu:diva-602734 (URN)10.1080/02813432.2026.2747915 (DOI)001907622100001 ()42894311 (PubMedID)2-s2.0-105054038067 (Scopus ID)
Forskningsfinansiär
Hjärt-LungfondenHjärt-Lungfonden
Tillgänglig från: 2026-11-02 Skapad: 2026-11-02 Senast uppdaterad: 2026-11-02Bibliografiskt granskad
Öfverholm, T., Hasselgren, M., Lisspers, K., Nager, A., Eliason, G., Giezeman, M., . . . Sandelowsky, H. (2026). Clinical factors associated with severely reduced health status in patients with COPD and comorbid depression/anxiety: The Swedish PRAXIS study. npj Primary Care Respiratory Medicine, 36(1), Article ID 29.
Öppna denna publikation i ny flik eller fönster >>Clinical factors associated with severely reduced health status in patients with COPD and comorbid depression/anxiety: The Swedish PRAXIS study
Visa övriga...
2026 (Engelska)Ingår i: npj Primary Care Respiratory Medicine, E-ISSN 2055-1010, Vol. 36, nr 1, artikel-id 29Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Patients with COPD and comorbid depression/anxiety are at risk of reduced health status. This study aimed to assess health status in COPD patients with depression/anxiety, the occurrence of severely reduced health status in this group, and to investigate associations between severely reduced health status and patient-related clinical factors. This cross-sectional study included 2245 randomly selected COPD patients from primary care and hospital outpatient clinics in Sweden. The COPD Assessment Test (CAT) and the Clinical COPD Questionnaire (CCQ) were used to assess health status. Severely reduced health status was defined as CAT >= 20 or CCQ >= 2. The 524 patients (23.3%) who reported depression/anxiety had higher mean CAT scores (18.3 vs. 15.2, p < 0.001) and CCQ scores (2.37 vs. 1.83, p < 0.001) than patients without depression/anxiety. In this group, 48% had CAT >= 20 and 57% had CCQ >= 2. In patients with depression/anxiety, factors associated with CAT >= 20 were: onset of COPD symptoms before 60 years of age (OR = 2.62 [95% CI 1.37-5.04]), frequent symptoms of depression in the previous three months (2.59 [1.55-4.30]), one or more COPD exacerbations in the previous six months (2.37 [1.41-4.00]) and physical inactivity (1.89 [1.11-3.22]). Apart from physical inactivity, factors associated with CCQ >= 2 were the same as for CAT >= 20. Approximately half of the COPD patients with comorbid depression/anxiety reported severely reduced health status. Exacerbations, frequent depressive symptoms and physical inactivity were factors associated with severely reduced health status, and constitute important treatable and preventable traits of COPD.

Ort, förlag, år, upplaga, sidor
Springer Nature, 2026
Nationell ämneskategori
Lungmedicin och allergi Folkhälsovetenskap, global hälsa och socialmedicin Psykiatri
Identifikatorer
urn:nbn:se:uu:diva-587517 (URN)10.1038/s41533-026-00522-5 (DOI)001768012200001 ()42143047 (PubMedID)2-s2.0-105039287801 (Scopus ID)
Forskningsfinansiär
Hjärt-LungfondenHjärt-Lungfonden
Tillgänglig från: 2026-06-01 Skapad: 2026-06-01 Senast uppdaterad: 2026-06-09Bibliografiskt granskad
Gonzalez Lindh, M., Bröms, K., Palm, A., Lisspers, K., Ställberg, B., Janson, C., . . . Malinovschi, A. (2026). COPD and Dysphagia, a 2-Year Follow-up of the Prospective TIE-Cohort Study. COPD: Journal of Chronic Obstructive Pulmonary Disease, 23(1), Article ID 2710155.
Öppna denna publikation i ny flik eller fönster >>COPD and Dysphagia, a 2-Year Follow-up of the Prospective TIE-Cohort Study
Visa övriga...
2026 (Engelska)Ingår i: COPD: Journal of Chronic Obstructive Pulmonary Disease, ISSN 1541-2555, E-ISSN 1541-2563, Vol. 23, nr 1, artikel-id 2710155Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background

Swallowing dysfunction (dysphagia) is increasingly recognised in chronic obstructive pulmonary disease (COPD) and has been associated with aspiration, exacerbations, and impaired health status. However, longitudinal data on dysphagia in COPD are limited.

Aim

To investigate the 2-year stability of self-perceived dysphagia in a COPD cohort and to identify factors associated with persistent dysphagia.

Methods

This prospective cohort study included 438 patients with spirometry-confirmed COPD from the Swedish Tools for Identifying Exacerbations (TIE) study. Self-reported swallowing symptoms were assessed at baseline and at 2-year follow-up using three questions. Dysphagia was defined as the presence of at least one symptom. Clinical assessments included lung function, dyspnoea (mMRC), health status (CAT), physical performance, body mass index (BMI), and exacerbation history. Dysphagia trajectories over time were analysed.

Results

The prevalence of patient-reported dysphagia remained stable over the 2-year period (32% at baseline vs. 33% at follow-up). Four dysphagia trajectories were identified: no dysphagia (59%), incident dysphagia (8%), remission (8%), and persistent dysphagia (25%). Participants with dysphagia at follow-up had higher dyspnoea and CAT scores, poorer physical performance, higher BMI, and more frequent exacerbations. Persistent dysphagia was associated with a consistently higher symptom burden and poorer functional outcomes over time. In multivariate analysis, CAT ≥10 remained independently associated with dysphagia.

Conclusion

Self-perceived dysphagia affects approximately one-third of individuals with COPD and remains stable over two years. Persistent dysphagia may identifiy a more symptomatic COPD phenotype and warrants clinical attention. These findings support the inclusion of simple swallowing screening in routine COPD follow-up.

Ort, förlag, år, upplaga, sidor
Routledge, 2026
Nyckelord
Subjective swallowing dysfunction, dysphagia, COPD, dyspnoea
Nationell ämneskategori
Lungmedicin och allergi
Identifikatorer
urn:nbn:se:uu:diva-595798 (URN)10.1080/15412555.2026.2710155 (DOI)001842413700001 ()42557931 (PubMedID)2-s2.0-105046617194 (Scopus ID)
Tillgänglig från: 2026-08-20 Skapad: 2026-08-20 Senast uppdaterad: 2026-08-20Bibliografiskt granskad
Wang, J., Ställberg, B., Hårdstedt, M., Bröms, K., Farkhooy, A., Palm, A., . . . Malinovschi, A. (2026). Health status and prognosis of COPD patients in relation to the FEV1/FVC ratio. npj Primary Care Respiratory Medicine, 36(1), Article ID 36.
Öppna denna publikation i ny flik eller fönster >>Health status and prognosis of COPD patients in relation to the FEV1/FVC ratio
Visa övriga...
2026 (Engelska)Ingår i: npj Primary Care Respiratory Medicine, E-ISSN 2055-1010, Vol. 36, nr 1, artikel-id 36Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Whether COPD should be diagnosed using the lower limit of normal (LLN) or a fixed FEV1/FVC ratio <0.70 (FR) is debated. We compared symptom and disease burden in COPD patients with FEV₁/FVC below both thresholds (FR + /LLN + ) versus those between them (FR + /LLN-). This cohort study included 572 COPD patients from primary and secondary care in the central Swedish regions of Dalarna, Gävleborg, and Uppsala. FR + /LLN + COPD patients with FEV1 ≥ 60% predicted (n = 194) was compared to FR + /LLN- COPD patients (n = 85) in order to have similar FEV1 levels in both groups. The symptom burden was assessed using the modified British Medical Research Council scale of dyspnoea (mMRC), the COPD Assessment Test (CAT), and the Clinical COPD Questionnaire (CCQ). The disease burden was assessed by exacerbations and hospital admissions over the subsequent three years. The 279 studied patients (57% females) had a mean age of 68.2 years and a mean FEV1% predicted of 73.0%. The FR + /LLN+ group had comparable clinical characteristics to the FR + /LLN- group regarding FEV1% predicted (72.5 vs 74.2%), use of inhaled medicines (76.3 vs 76.5%), and previous exacerbations (23.2 vs 18.8%), all p-values > 0.05. Moreover, comparable prevalence of exacerbations and hospital admissions were found during the subsequent three years (31.7 vs 37.7%, and 4.8 vs 2.6%, respectively, all p-values > 0.05). Symptom burden was comparable for mMRC and CCQ, but the FR + /LLN- group had a higher CAT score than the FR + /LLN+ group (10.6 vs 12.6, p = 0.038), a finding also confirmed in adjusted analyses. FR + /LLN+ and FR + /LLN- COPD patients had relatively comparable symptom and disease burden, suggesting that not meeting the LLN criteria does not indicate a milder disease in clinically diagnosed COPD with comparable FEV1.

Ort, förlag, år, upplaga, sidor
Springer Nature, 2026
Nationell ämneskategori
Lungmedicin och allergi
Identifikatorer
urn:nbn:se:uu:diva-575190 (URN)10.1038/s41533-025-00478-y (DOI)001658749800001 ()41507184 (PubMedID)2-s2.0-105027041158 (Scopus ID)
Tillgänglig från: 2026-01-09 Skapad: 2026-01-09 Senast uppdaterad: 2026-03-18Bibliografiskt granskad
Öfverholm, T., Hasselgren, M., Lisspers, K., Nager, A., Eliason, G., Giezeman, M., . . . Sandelowsky, H. (2026). High proportion of depression and anxiety in younger patients with COPD: a cross-sectional study in primary care in Sweden. Scandinavian Journal of Primary Health Care, 44(1), 1-10
Öppna denna publikation i ny flik eller fönster >>High proportion of depression and anxiety in younger patients with COPD: a cross-sectional study in primary care in Sweden
Visa övriga...
2026 (Engelska)Ingår i: Scandinavian Journal of Primary Health Care, ISSN 0281-3432, E-ISSN 1502-7724, Vol. 44, nr 1, s. 1-10Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

BACKGROUND AND AIM: Patients with COPD and concurrent depression and/or anxiety are known to have an increased risk of exacerbations, morbidity, mortality, and deteriorated quality of life. Early detection of depression/anxiety may enable early interventions. The aims of this study were to describe the occurrence of depression and anxiety in primary care patients with COPD in Sweden, and to investigate age and gender differences together with other clinical factors associated with this comorbidity.

METHODS: A cross-sectional study was performed on a cohort of patients with doctor's diagnoses of COPD. Patients were randomly selected based on the patients' contact with 98 primary healthcare centers and 13 hospitals in Sweden in 2014. Information about self-reported depression/anxiety, patient characteristics, symptoms, and comorbidity, were collected using patient self-completion questionnaires. Lung function data were extracted from medical records.

RESULTS: Of the 2245 patients recruited, 23% (n = 524) reported depression/anxiety, 29% in women and 16% in men (p <0.001). Factors associated with depression/anxiety were being a woman (OR = 2.06 [95% CI 1.56-2.72]), current smoking (1.83 [1.37-2.43]), comorbid asthma (1.77 [1.32-2.37]), dyspnea (the modified Medical Research Council dyspnea scale ≥2 points) (1.58 [1.17-2.13]) and age <65 years (1.57 [1.17-2.10]). The youngest age groups had the highest proportions of patients with depression/anxiety.

CONCLUSIONS: Healthcare professionals need to be particularly aware of depression/anxiety in patients with COPD who are younger, women, current smokers, have comorbid asthma, or dyspnea.

Ort, förlag, år, upplaga, sidor
Taylor & Francis, 2026
Nyckelord
COPD, anxiety, depression, early COPD, observational studies, primary health care
Nationell ämneskategori
Lungmedicin och allergi
Identifikatorer
urn:nbn:se:uu:diva-571074 (URN)10.1080/02813432.2025.2526667 (DOI)001523689600001 ()40619171 (PubMedID)2-s2.0-105010045814 (Scopus ID)
Tillgänglig från: 2025-11-06 Skapad: 2025-11-06 Senast uppdaterad: 2026-05-13Bibliografiskt granskad
Smith, C., Hiyoshi, A., Arnison, T., Eliason, G., Giezeman, M., Hasselgren, M., . . . Montgomery, S. (2026). Risk factors for COPD exacerbations and mortality, and variation between primary care settings: the PRAXIS cohort study in Sweden. FAMILY MEDICINE AND COMMUNITY HEALTH, 14(1), Article ID e003713.
Öppna denna publikation i ny flik eller fönster >>Risk factors for COPD exacerbations and mortality, and variation between primary care settings: the PRAXIS cohort study in Sweden
Visa övriga...
2026 (Engelska)Ingår i: FAMILY MEDICINE AND COMMUNITY HEALTH, ISSN 2305-6983, Vol. 14, nr 1, artikel-id e003713Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Objective We aimed to examine the variability of chronic obstructive pulmonary disease (COPD) exacerbations and mortality, between primary healthcare centres, and their associations with comorbid diseases and body mass index, during an 8-year follow-up.Design This was a cohort study using multilevel modelling with follow-up from 2014 to 2022. Data came from questionnaires in 2014 and 2022 and medical record reviews between 2004 and 2014. The main outcomes were exacerbations in 2022 and mortality by 2022. Exacerbations were defined as any emergency visit, and/or use of oral steroids or antibiotics due to worsening of COPD symptoms during the previous 6 months.Setting The PRAXIS study included patients at 76 primary healthcare centres in central Sweden.Participants Primary care patients aged <= 75 years and with a diagnosis of COPD in their medical records between 2007 and 2010 were included in 2014 (n=1163) and followed up in 2022 (n=906). There were no other exclusion criteria.Results The 809 patients with complete data attended 70 primary care centres. Multilevel multinomial regression estimated risks of exacerbations and mortality, calculating relative risk ratios (RRRs) with 95% CIs. The intraclass correlation coefficient (ICC) quantified the proportion of variance attributed to variability between centres. The ICC was 0.024, indicating 2.4% of the variation was explained by differences between centres. Patients with a history of depression in 2014 had an increased risk of subsequent exacerbations (RRR 1.95, 95% CI 1.13 to 3.39). For mortality, there were associations with history of anxiety, RRR 3.71 (95% CI 2.06 to 6.87), or cardiovascular disease, especially chronic heart failure, RRR 2.69 (95% CI 1.36 to 5.33). Body mass index had a U-shaped association with mortality.Conclusions The variability between centres was small and patient factors appear to be of more importance for COPD exacerbations and mortality than differences between these primary care settings. As expected, pre-existing cardiovascular disease is associated with future excess mortality risk, but, notably, anxiety may also be an important risk factor. Individualised care and management of comorbidity is thus essential among patients in primary care with COPD.

Ort, förlag, år, upplaga, sidor
BMJ Publishing Group Ltd, 2026
Nyckelord
Respiratory System, Chronic Disease, Primary Health Care, Epidemiology
Nationell ämneskategori
Lungmedicin och allergi
Identifikatorer
urn:nbn:se:uu:diva-582104 (URN)10.1136/fmch-2025-003713 (DOI)001696830300001 ()41720490 (PubMedID)2-s2.0-105030785772 (Scopus ID)
Forskningsfinansiär
Hjärt-Lungfonden, 20210359Vetenskapsrådet, 2023-05997Hjärt-Lungfonden, FA 2022-42
Tillgänglig från: 2026-03-23 Skapad: 2026-03-23 Senast uppdaterad: 2026-03-23Bibliografiskt granskad
Andreason, A., Ställberg, B., Lisspers, K., Nager, A., Sandelowsky, H., Sundh, J., . . . Kisiel, M. (2026). Risk factors of post-COVID-19 symptoms, a cross-sectional study in patients with asthma and chronic obstructive lung disease. npj Primary Care Respiratory Medicine, 36, Article ID 64.
Öppna denna publikation i ny flik eller fönster >>Risk factors of post-COVID-19 symptoms, a cross-sectional study in patients with asthma and chronic obstructive lung disease
Visa övriga...
2026 (Engelska)Ingår i: npj Primary Care Respiratory Medicine, E-ISSN 2055-1010, Vol. 36, artikel-id 64Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Post-COVID-19 symptoms are common following COVID-19, but risk factors of persistent symptoms in patients with asthma and chronic obstructive lung disease (COPD) remain unclear. We aimed to assess the frequency and risk factors of post-COVID-19 symptoms in patients with asthma and COPD. In this cross-sectional study, we used data from the Swedish PRAXIS study collected in 2022. The cohort included randomly selected adult patients with a diagnosis of asthma or COPD in medical records from central Sweden's primary and secondary care. Participants completed a comprehensive questionnaire, and their responses were analysed. We used logistic regression and adjusted for age and lung disease diagnoses. Among 494 patients with confirmed COVID-19, 59% (289/494) reported post-COVID-19 symptoms. Risk factors for post-COVID-19 symptoms included severe acute infection (adjusted odds ratio aOR: 8.91, 95% confidence interval [CI]: 3.49-22.8), higher age (aOR:1.25, 95% CI: 1.09-1.45), female sex (aOR: 1.52, 95% CI: 1.04-2.21), and obesity [BMI ≥30] (aOR: 2.24, 95% CI: 1.44-3.47)). Anxiety/depression (aOR:1.79, 95% CI: 1.13-2.80) and chronic pain (aOR: 3.61, 95% CI: 1.95-6.69) were also significant risk factors. Patients with asthma or COPD had a high prevalence of post-COVID-19 symptoms compared to other studies. Several demographic and clinical factors were associated with post-COVID-19 symptoms, which could help identify patients at increased risk.

Ort, förlag, år, upplaga, sidor
Springer Nature, 2026
Nationell ämneskategori
Lungmedicin och allergi Infektionsmedicin Folkhälsovetenskap, global hälsa och socialmedicin
Identifikatorer
urn:nbn:se:uu:diva-601306 (URN)10.1038/s41533-026-00570-x (DOI)001886933000001 ()42805994 (PubMedID)2-s2.0-105051995999 (Scopus ID)
Forskningsfinansiär
Svenska läkaresällskapet, SLS-999315Region UppsalaUppsala universitet
Tillgänglig från: 2026-10-13 Skapad: 2026-10-13 Senast uppdaterad: 2026-10-13Bibliografiskt granskad
Eliason, G., Ekström, M., Montgomery, S., Giezeman, M., Hasselgren, M., Janson, C., . . . Sundh, J. (2025). Associations of comorbid heart disease and depression/anxiety with multidimensional breathlessness in COPD: A cross-sectional study. Respiratory Medicine, 241, Article ID 108053.
Öppna denna publikation i ny flik eller fönster >>Associations of comorbid heart disease and depression/anxiety with multidimensional breathlessness in COPD: A cross-sectional study
Visa övriga...
2025 (Engelska)Ingår i: Respiratory Medicine, ISSN 0954-6111, E-ISSN 1532-3064, Vol. 241, artikel-id 108053Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background

Comorbid conditions and breathlessness are associated with poor outcomes in chronic obstructive pulmonary disease (COPD). We evaluated the associations of comorbid heart disease and depression/anxiety with breathlessness in daily life among people with COPD.

Methods

Cross-sectional analysis from the PRAXIS cohort in central Sweden. Data on patient characteristics and the modified Medical Research Council (mMRC) and Dyspnea-12 breathlessness instruments (D-12) were obtained from questionnaires in 2022. Lung function data were collected from record review. Outcome variables were clinically significant breathlessness defined as mMRC≥2 and D-12 total (>2.7), physical (>1.4) and affective (>1.2) scores above published minimal clinical important differences. Associations of heart disease and depression/anxiety with each outcome were analyzed using multivariable Poisson regression adjusted for relevant confounders.

Results

In 522 included patients, mMRC ≥2 was present in 59 % and increased D-12 total, physical and affective domain scores in 69 %, 74 %, and 50 %, respectively. Heart disease was independently associated with mMRC (relative risk ratio [95 % confidence interval] 1.34 [1.17–1.53]), D12 physical domain (1.12[1.02–1.24]) and D-12 affective domain (1.20[1.02–1.42]). Depression/anxiety was independently associated with increased D-12 affective domain (1.25[1.04–1.49]). In addition, previous exacerbations and GOLD stage 3–4 were associated with mMRC and D-12, respectively.

Conclusion

In COPD, comorbid heart disease is associated with both activity-related breathlessness and with physical and affective domains of breathlessness while depression/anxiety is associated with the affective domain of breathlessness. As the influence of different dimensions of breathlessness may differ according to comorbidity the D-12 instrument adds more information when assessing breathlessness in patients with COPD.

Ort, förlag, år, upplaga, sidor
Elsevier, 2025
Nyckelord
Activity-related breathlessness, Dyspnea dimensions, Dyspnea, Heart disease, Depression, Anxiety
Nationell ämneskategori
Lungmedicin och allergi
Identifikatorer
urn:nbn:se:uu:diva-555372 (URN)10.1016/j.rmed.2025.108053 (DOI)001465221800001 ()40157398 (PubMedID)2-s2.0-105001706007 (Scopus ID)
Tillgänglig från: 2025-04-28 Skapad: 2025-04-28 Senast uppdaterad: 2025-04-28Bibliografiskt granskad
Sandelowsky, H. & Ställberg, B. (2025). Astma i primärvården: [Asthma in primary care]. Läkartidningen, 15(122), Article ID 24138.
Öppna denna publikation i ny flik eller fönster >>Astma i primärvården: [Asthma in primary care]
2025 (Svenska)Ingår i: Läkartidningen, ISSN 0023-7205, E-ISSN 1652-7518, Vol. 15, nr 122, artikel-id 24138Artikel, forskningsöversikt (Refereegranskat) Published
Abstract [sv]

Diagnostik och uppföljning av majoriteten av patienter med astma sker i primärvården. 

Den varierande luftvägsobstruktionen gör att astmadia­gnostik kan vara svår. Anamnes och lungfunktionsmätningar är grundstenen. 

Även de med enbart sporadiska symtom ska ges behandling med inhalationssteroider (steg 1). 

Patientutbildning är avgörande för god astmakontroll.

Optimal astmakontroll innebär normal lungfunktion, symtomfrihet och avsaknad av exacerbationer. Detta ska alltid bedömas. 

Vid okontrollerad astma bör behandlingsbarriärer såsom bristande inhalationsteknik, otillräcklig följsamhet till behandling, exponering för utlösande faktorer och eventuell påverkan av samsjuklighet bedömas.

Ort, förlag, år, upplaga, sidor
Läkartidningen AB, 2025
Nationell ämneskategori
Lungmedicin och allergi
Identifikatorer
urn:nbn:se:uu:diva-575455 (URN)40371568 (PubMedID)
Tillgänglig från: 2026-01-12 Skapad: 2026-01-12 Senast uppdaterad: 2026-04-17Bibliografiskt granskad
Ellingsen, J., Janson, C., Bröms, K., Farkhooy, A., Hårdstedt, M., Högman, M., . . . Malinovschi, A. (2025). Clinical phenotypes predict exacerbations of COPD: the TIE cohort study. Respiratory Medicine, 244, Article ID 108182.
Öppna denna publikation i ny flik eller fönster >>Clinical phenotypes predict exacerbations of COPD: the TIE cohort study
Visa övriga...
2025 (Engelska)Ingår i: Respiratory Medicine, ISSN 0954-6111, E-ISSN 1532-3064, Vol. 244, artikel-id 108182Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background: In 2017, Burgel and colleagues developed an algorithm to identify clinical phenotypes that predict mortality in COPD. Our study aimed to 1) investigate whether the phenotypes can predict acute exacerbations of COPD (AECOPD) and 2) validate their ability to predict mortality.

Methods: The Tools Identifying Exacerbations (TIE) cohort study recruited participants with spirometry-verified COPD from primary and secondary care in three Swedish regions. Participants were allocated to phenotypes 1–5 using the previously developed algorithm containing comorbidities (heart failure, coronary artery disease, hypertension, and/or diabetes), dyspnoea, age, forced expiratory volume in 1 s (FEV1), and body mass index (BMI). Data on AECOPDs and deaths during the three-year follow-up were collected from medical records and analysed with Cox proportional hazards regressions. Harrel's C-index was used to assess the models' discriminative ability.

Results: Among the 566 participants, 59 % were female, and the mean ± SD FEV1 was 57 ± 18 % of predicted. The hazard ratios (HRs) [95 % CI] for time to AECOPD were 3.04 [1.93–4.79], 2.38 [1.54–3.66], and 3.52 [1.73–7.15] in phenotypes 1, 2, and 4 compared with 5 (C-index = 0.61). When AECOPD history was used to predict future AECOPD the C-index was 0.65.The HRs [95 % CI] for mortality were 8.24 [1.93–35.3], 6.26 [1.40–28.0], and 16.7 [3.25–86.3] in phenotypes 1, 3, and 4 compared to 5 (C-index = 0.68). For AECOPD history, the C-index was 0.55.

Conclusion: Clinical COPD phenotypes based on comorbidities, dyspnoea, age, FEV1, and BMI predict AECOPDs but do not perform better than AECOPD history. However, they perform better than AECOPD history in predicting mortality.

Ort, förlag, år, upplaga, sidor
Elsevier, 2025
Nationell ämneskategori
Lungmedicin och allergi
Forskningsämne
Lungmedicin
Identifikatorer
urn:nbn:se:uu:diva-523302 (URN)10.1016/j.rmed.2025.108182 (DOI)001501680100002 ()2-s2.0-105006767605 (Scopus ID)
Tillgänglig från: 2024-02-22 Skapad: 2024-02-22 Senast uppdaterad: 2025-10-28Bibliografiskt granskad
Organisationer
Identifikatorer
ORCID-id: ORCID iD iconorcid.org/0000-0001-8497-7326

Sök vidare i DiVA

Visa alla publikationer